These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 781134)

  • 1. Demonstration of binding sites for IgG Fc and the third complement component (C3) on isolated hepatocytes.
    Hopf U; Meyer zum Büschenfelde KH; Dierich MP
    J Immunol; 1976 Aug; 117(2):639-45. PubMed ID: 781134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Circulating immune complexes and in vivo fixation of immunoglobulin G, A and C3 onto hepatocytes in patients with Crohn's disease (author's transl)].
    Eckhardt R; Hopf U; Hütteroth TH; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1978 Dec; 16(12):739-47. PubMed ID: 741844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding sites for endotoxic lipopolysaccharide on the plasma membrane of isolated rabbit hepatocytes.
    Ramadori G; Hopf U; Meyer zum Büschenfelde KH
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):368-74. PubMed ID: 393040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement fixation in acute serum sickness: assembly of glomerular-bound C3-convertase.
    Bartolotti SR; Peters DK
    Clin Exp Immunol; 1979 Sep; 37(3):391-8. PubMed ID: 389495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for the Fc portion of IgG on the plasma membrane of the hepatocyte.
    Frommel D; Rachman R
    Ann Immunol (Paris); 1979; 130C(4):553-60. PubMed ID: 496402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed removal of renal-bound antigen in decomplemented rabbits with acute serum sickness.
    Bartolotti SR; Peters DK
    Clin Exp Immunol; 1978 May; 32(2):199-206. PubMed ID: 352585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of IgG-Fc and C3 receptors on adult Schistosoma mansoni.
    Tarleton RL; Kemp WM
    J Immunol; 1981 Jan; 126(1):379-84. PubMed ID: 7451978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Raji cell radioimmune assay for detecting immune complexes in human sera.
    Theofilopoulos AN; Wilson CB; Dixon FJ
    J Clin Invest; 1976 Jan; 57(1):169-82. PubMed ID: 128562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells.
    McConnell I; Hurd CM
    Immunology; 1976 Jun; 30(6):825-33. PubMed ID: 800392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG on lymphocyte surfaces; technical problems and the significance of a third cell population.
    Winchester RJ; Fu SM; Hoffman T; Kunkel HG
    J Immunol; 1975 Apr; 114(4):1210-2. PubMed ID: 804005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN; Dixon FJ; Bokisch VA
    J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
    Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
    J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on the biologic properties of guinea pig IgG1 antibodies. II. In vivo activation of C3 by anti-glomerular basement membrane antibodies.
    Vuagnat P
    J Immunol; 1975 Sep; 115(3):787-95. PubMed ID: 50374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for immunoglobulin and complement on human alveolar macrophages.
    Reynolds HY; Atkinson JP; Newball HH; Frank MM
    J Immunol; 1975 Jun; 114(6):1813-9. PubMed ID: 1127229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.
    Goldstein IM; Kaplan HB; Radin A; Frosch M
    J Immunol; 1976 Oct; 117(4):1282-7. PubMed ID: 185296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of Fc and C3 receptors on myeloid leukemic cells.
    Lotem J; Sachs L
    J Immunol; 1976 Aug; 117(2):580-6. PubMed ID: 950462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.